Status:
COMPLETED
Developing a Mobile Method to Measure THC-induced Impairment
Lead Sponsor:
University of Chicago
Conditions:
Measuring THC-induced Cognitive Impairment Using a Mobile Application
Eligibility:
All Genders
18-35 years
Phase:
EARLY_PHASE1
Brief Summary
Marijuana use, for both recreational and therapeutic purposes, is becoming increasingly common as states remove restrictions on use. The increased use raises new concern about the safety of this drug,...
Eligibility Criteria
Inclusion
- 18-35 years old, males and females (N=44; 36 completers; 18 men, 18 women)
- BMI 19-26
- High school education, fluent in English
- Experienced non-daily marijuana users
Exclusion
- Current drug/alcohol abuse or dependence
- Past year drug/alcohol dependence
- Diagnosis with drug treatment for psychosis/bipolar/schizophrenia
- Past year major depression
- Panic/anxiety attacks in past 2 months
- Post Traumatic Stress Disorder
- Attention Deficit Hyperactivity Disorder
- Cardiovascular illness, high blood pressure, abnormal EKG
- Current medications
- Pregnant or planning to become pregnant
Key Trial Info
Start Date :
March 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2018
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT03804840
Start Date
March 1 2017
End Date
December 1 2018
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Chicago
Chicago, Illinois, United States, 60615